20(S)-Protopanaxadiol-Induced Apoptosis in MCF-7 Breast Cancer Cell Line through the Inhibition of PI3K/AKT/mTOR Signaling Pathway.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI, [2000-

Apoptosis/*drug effects ; Phosphatidylinositol 3-Kinases/*metabolism ; Proto-Oncogene Proteins c-akt/*metabolism ; Sapogenins/*pharmacology ; TOR Serine-Threonine Kinases/*metabolism; Cell Line, Tumor ; Female ; Humans ; MCF-7 Cells ; Signal Transduction/drug effects

20(S)-Protopanaxadiol (PPD) is one of the major active metabolites of ginseng. It has been reported that 20(S)-PPD shows a broad spectrum of antitumor effects. Our research study aims were to investigate whether apoptosis of human breast cancer MCF-7 cells could be induced by 20(S)-PPD by targeting the Phosphatidylinositol 3-kinase/Protein kinase B/Mammalian target of rapamycin (PI3K/AKT/mTOR) signal pathway in vitro and in vivo. Cell cycle analysis was performed by Propidium Iodide (PI) staining. To overexpress and knock down the expression of mTOR, pcDNA3.1-mTOR and mTOR small interfering RNA (siRNA) transient transfection assays were used, respectively. Cell viability and apoptosis were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)-test and Annexin V /PI double-staining after transfection. The antitumor effect in vivo was determined by the nude mice xenograft assay. After 24 h of incubation, treatment with 20(S)-PPD could upregulate phosphorylated-Phosphatase and tensin homologue deleted on chromosome 10 (p-PTEN) expression and downregulate PI3K/AKT/mTOR-pathway protein expression. Moreover, G0/G1 cell cycle arrest in MCF-7 cells could be induced by 20(S)-PPD treatment at high concentrations. Furthermore, overexpression or knockdown of mTOR could inhibit or promote the apoptotic effects of 20(S)-PPD. In addition, tumor volumes were partially reduced by 20(S)-PPD at 100 mg/kg in a MCF-7 xenograft model. Immunohistochemical staining indicated a close relationship between the inhibition of tumor growth and the PI3K/AKT/mTOR signal pathway. PI3K/AKT/mTOR pathway-mediated apoptosis may be one of the potential mechanisms of 20(S)-PPD treatment.
Competing Interests: The authors declare no conflict of interest.

Int J Cancer. 2015 Mar 1;136(5):E359-86. (PMID: 25220842)
Curr Med Chem. 2012;19(7):1065-75. (PMID: 22229414)
Asian Pac J Cancer Prev. 2014;15(18):7919-23. (PMID: 25292087)
Oncotarget. 2017 Mar 7;8(10 ):17216-17228. (PMID: 28212547)
Cancer Cell. 2003 Oct;4(4):257-62. (PMID: 14585353)
Breast Cancer Res Treat. 2012 Feb;132(1):29-39. (PMID: 21512767)
Am J Chin Med. 2013;41(5):1137-52. (PMID: 24117074)
Oncologist. 2011;16 Suppl 1:12-9. (PMID: 21278436)
Nat Rev Genet. 2006 Aug;7(8):606-19. (PMID: 16847462)
Cancer. 2007 Jun 1;109(11):2374-82. (PMID: 17464948)
Proc Natl Acad Sci U S A. 1984 Apr;81(7):2117-21. (PMID: 6326105)
J Nat Prod. 2007 Feb;70(2):259-64. (PMID: 17261067)
Int J Cancer. 2017 Feb 1;140(3):495-503. (PMID: 27553713)
Free Radic Biol Med. 2012 May 1;52(9):1987-99. (PMID: 22366652)
Nature. 1985 May 16-22;315(6016):239-42. (PMID: 2987699)
Int J Cancer. 2016 Sep 15;139(6):1281-8. (PMID: 27176735)
CA Cancer J Clin. 2015 Mar;65(2):87-108. (PMID: 25651787)
CA Cancer J Clin. 2013 Jan;63(1):11-30. (PMID: 23335087)
Pharmacol Ther. 2016 Feb;158:63-70. (PMID: 26645663)
Science. 2004 Apr 23;304(5670):554. (PMID: 15016963)
J Hematol Oncol. 2017 Apr 28;10 (1):98. (PMID: 28454587)
Breast Cancer Res. 2016 Feb 09;18(1):17. (PMID: 26857361)
Oncotarget. 2017 Jun 13;8(24):39443-39459. (PMID: 28467796)
Lancet. 2017 Feb 25;389(10071):871-880. (PMID: 27814964)
Toxicol Appl Pharmacol. 2004 Feb 1;194(3):221-9. (PMID: 14761678)
Prostate. 2008 Jun 1;68(8):809-19. (PMID: 18324646)
Biol Pharm Bull. 2009 Sep;32(9):1552-8. (PMID: 19721231)
Science. 2002 Jul 5;297(5578):63-4. (PMID: 12098689)
Oncogene. 2008 Sep 18;27(41):5497-510. (PMID: 18794884)
Cancer Res. 2004 Jul 1;64(13):4394-9. (PMID: 15231645)

Keywords: 20(S)-Protopanaxadiol; MCF-7; PI3K/AKT/mTOR; apoptosis

0 (Sapogenins)
EC 2.7.1.1 (MTOR protein, human)
EC 2.7.11.1 (Proto-Oncogene Proteins c-akt)
EC 2.7.11.1 (TOR Serine-Threonine Kinases)
P6717R7BP8 (protopanaxadiol)

Date Created: 20180405 Date Completed: 20180910 Latest Revision: 20220408

20231215

PMC5979555

10.3390/ijms19041053

29614812